๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cirrhosis
Clinical trial register · China

Cirrhosis Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Yangzhou 5 Shenyang 3 Shanghai 3 Guangzhou 3 Chongqing 2
Narrow the registerReset
Recruitment status
Phase
Site location
Yangzhou5 Shenyang3 Shanghai3 Guangzhou3 Chongqing2
All 17 locations
Target enrolment
to

Cirrhosis trials in China

20 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9
NCT07652203Cirrhosis
General Hospital of Shenyang Military Region
Not applicable
466
Shenyang
2026-09
Not yet open
Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07585773Cirrhosis, Splenectomy; Status, Hypersplenism, Kidney Function Issue
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Not yet open
Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
NCT07588373Cirrhosis, Splenectomy; Status, Hypersplenism, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Recruiting
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
NCT07461532Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2026-04-01
Recruiting
Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
NCT07461545Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2026-04-01
Active, closed
Clinical Characteristics of Recompensation
NCT07651683Cirrhosis, Alcohol Related Liver Disease, HBV (Hepatitis B Virus), Recompensation
Third Affiliated Hospital, Sun Yat-Sen University
Observational
300
Guangzhou
2026-03-31
Recruiting
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
NCT07462091Cirrhosis, Hypersplenism, Hypertension, Portal
Northern Jiangsu People's Hospital
Not applicable
15
Yangzhou
2026-03-25
Recruiting
TIPS With or Without BCAA
NCT07281846BCAA, Cirrhosis, Portal Hypertension Related to Cirrhosis, Sarcopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
164
Wuhan
2025-11-15
Recruiting
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035Cirrhosis, Decompensation, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Survival Analysis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
250
Changsha, Fuzhou, Huanggang, Jingzhou, Nanchang, Nanjing, Shenyang, Taiyuan
2025-08-01
Recruiting
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335Cirrhosis, Hepotacellular Carcinoma
The First Affiliated Hospital of University of South China
Observational
800
Hengyang
2025-05-16
Recruiting
Exploring Clinical Characteristics of Liver Disease Patients Based on Digestive Metabolic Exhaled Air
NCT06968234Cirrhosis, Microbiota, Breath Tests
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-03-01
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Guangzhou, Shanghai
2025-01-20
Recruiting
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
NCT06316869Portal Hypertension, Cirrhosis
First Affiliated Hospital of Wenzhou Medical University
Observational
216
Wenzhou
2024-09-02
By invitation
Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnostic Experiment
NCT06995846Cirrhosis, Ascites, Bacterial Infections
Beijing YouAn Hospital
Observational
700
Beijing
2024-04-02
Recruiting
The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models
NCT06328517Cirrhosis
Juan Kang
Observational
300
Chongqing
2023-11-01
Recruiting
Exploration of a Novel Prognostic Prediction Model for Liver Cirrhosis
NCT07031843Cirrhosis
Juan Kang
Observational
300
Chongqing
2023-02-01
Recruiting
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
NCT06205992Cirrhosis, Liver Portal Hypertension
Shengjing Hospital
Observational
100
Shenyang
2022-08-16
Recruiting
EUS Guided Portal-systemic Pressure Gradient Measurement
NCT04633356Portal Hypertension, Cirrhosis
Chinese University of Hong Kong
Phase 1/2
30
Hong Kong
2020-11-12
Recruiting
Indicators Affecting PVT Recanalization
NCT07473375Portal Vein Thrombosis, Cirrhosis, Portal Hypertension Related to Cirrhosis, Portal Hypertension, Noncirrhotic
Shanghai Zhongshan Hospital
Observational
1,500
Shanghai
2017-01-01
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/cirrhosis

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies listing the condition Cirrhosis.

How many Cirrhosis trials are recruiting in China?

14 of the 20 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cirrhosis), 20 studies
PhaseStudiesRecruitingShare
Observational14970%
Not applicable5425%
Phase 1/2115%

Most active sponsors

Lead sponsors with the most studies (Cirrhosis)
Lead sponsorStudiesRecruiting
Northern Jiangsu People's Hospital53
Chinese University of Hong Kong22
Juan Kang22
Shanghai Zhongshan Hospital22
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology22
Beijing YouAn Hospital10
First Affiliated Hospital of Wenzhou Medical University11
General Hospital of Shenyang Military Region10
Shengjing Hospital11
The First Affiliated Hospital of University of South China11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.